FDA's Makary looks at ways to speed drug approvals, talks about cutting user fees

Zachary Brennan

Senior Editor

FDA Commissioner Marty Makary said that he is open to reworking the drug approval process in ways that will be advantageous to the biopharma industry …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA's Makary looks at ways to speed drug approvals, talks about cutting user fees

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Biotech ranks as China’s best shot to surpass US in emerging tech, report finds

Biopharma leaders carving a path for the industry’s LGBTQ+ community

GSK taps Sanofi vet to lead vaccine R&D; Bristol Myers names head of corporate affairs

Otsuka spells out Phase 3 win in rare kidney disease, Vera’s stock takes a hit

Omada Health is going public on Friday at a $1.1B valuation

Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy ...

FDA's Makary looks at ways to speed drug ap­provals, talks about cut­ting user fees

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Biotech ranks as Chi­na’s best shot to sur­pass US in emerg­ing tech, re­port finds

Bio­phar­ma lead­ers carv­ing a path for the in­dus­try’s LGBTQ+ com­mu­ni­ty

GSK taps Sanofi vet to lead vac­cine R&D; Bris­tol My­ers names head of cor­po­rate af­fairs

Ot­su­ka spells out Phase 3 win in rare kid­ney dis­ease, Ve­ra’s stock takes a hit

Oma­da Health is go­ing pub­lic on Fri­day at a $1.1B val­u­a­tion

Cy­ti­va and Eu­rek­aBio form strate­gic part­ner­ship to ad­vance lentivi­ral vec­tor man­u­fac­tur­ing for cell and gene ther­a­py ...

FDA's Makary looks at ways to speed drug approvals, talks about cutting user fees

Biotech ranks as China’s best shot to surpass US in emerging tech, report finds

Biopharma leaders carving a path for the industry’s LGBTQ+ community

GSK taps Sanofi vet to lead vaccine R&D; Bristol Myers names head of corporate affairs

Otsuka spells out Phase 3 win in rare kidney disease, Vera’s stock takes a hit

Omada Health is going public on Friday at a $1.1B valuation

Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy ...